Original Research

Published on 19 Dec 2023

Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment

in Thoracic Oncology

Yongxia Chen
Mengye He
Zhengfeng Dai
Yina Wang
Jing Chen
Xiaoting Wang
Xiao Dong
Jianfei Huang
Jian Ruan
Xiaochen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1308313

1,797 views
2 citations

Correction

Published on 19 Dec 2023

Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients

in Thoracic Oncology

Keying Jing
Huijuan Zhao
Jun Cai
Lianlian Chen
Peiming Zheng
Libo Ouyang
Gang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1353702

535 views

Review

Published on 19 Dec 2023

Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer

in Thoracic Oncology

Yanting Wang
Tao Zhang
Xin He

Frontiers in Oncology

doi 10.3389/fonc.2023.1279822

1,921 views
3 citations

Original Research

Published on 13 Dec 2023

TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism

in Thoracic Oncology

Xunbo Zheng
Li Han
Jun Guan
Chenteng Chen
Yue Zhang
Jiali Zhang
Yiran Zhang
Siyao Liu
Junyan Su
Mengyuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1274439

2,400 views
1 citation

Review

Published on 11 Dec 2023

AI/ML advances in non-small cell lung cancer biomarker discovery

in Thoracic Oncology

Minal Çalışkan
Koichi Tazaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1260374

3,049 views
2 citations

Review

Published on 08 Dec 2023

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

in Thoracic Oncology

Sukumar Kalvapudi
Yeshwanth Vedire
Sai Yendamuri
Joseph Barbi

Frontiers in Oncology

doi 10.3389/fonc.2023.1286104

5,310 views
4 citations

Case Report

Published on 06 Dec 2023

High-grade fetal adenocarcinoma of the lung misdiagnosed as male breast carcinoma: a case report and literature review

in Thoracic Oncology

Yuejian Zhuo
Yanran Xu
Rong Qin
Min Guo
Dongdong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1293534

1,156 views

Original Research

Published on 06 Dec 2023

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada

in Thoracic Oncology

David E. Dawe
Rebekah Rittberg
Iqra Syed
Mary Kate Shanahan
Daniel Moldaver
Oliver Bucher
Katie Galloway
Kayla Reynolds
James T. Paul
Craig Harlos

Frontiers in Oncology

doi 10.3389/fonc.2023.1191920

2,081 views
1 citation

Review

Published on 05 Dec 2023

Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review

in Thoracic Oncology

Jiamin Xu
Zhongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1285593

1,762 views

Original Research

Published on 04 Dec 2023

Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study

in Thoracic Oncology

Yumin Zheng
Kexin Tan
Aolin Wang
Xingyu Lu
Huijing Dong
Jia Li
Huijuan Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1287628

2,052 views
1 citation

Original Research

Published on 04 Dec 2023

PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma

in Thoracic Oncology

Alejandro Avilés-Salas
Luis Cabrera-Miranda
Norma Hernández-Pedro
Diana Sofía Vargas-Lías
Suraj Samtani
Wendy Muñoz-Montaño
Daniel Motola-Kuba
Luis Corrales-Rodríguez
Claudio Martín
Andrés F. Cardona

Frontiers in Oncology

doi 10.3389/fonc.2023.1269029

1,856 views

Systematic Review

Published on 01 Dec 2023

Influence of treatment-related lymphopenia on the efficacy of immune checkpoint inhibitors in lung cancer: a meta-analysis

in Thoracic Oncology

Ye Zhang
Cheng Huang
Shanqing Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1287555

1,454 views
5 citations

Case Report

Published on 27 Nov 2023

Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report

in Thoracic Oncology

Wenxing Yang
Ze Yang
Kaiqiang Wang
Peiquan Zhu
Jiangtao Pu

Frontiers in Oncology

doi 10.3389/fonc.2023.1279045

1,160 views
2 citations

Case Report

Published on 23 Nov 2023

Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report

in Thoracic Oncology

Yan Li
Lili Liu
Dongfeng Wang
Xiaojing Tan
Yanmin Sui
Honglan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1257931

1,118 views
2 citations

Editorial

Published on 23 Nov 2023

Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer

in Thoracic Oncology

Carlos Gil Ferreira
Marina Xavier Reis
Gilson Gabriel Viana Veloso

Frontiers in Oncology

doi 10.3389/fonc.2023.1308525

1,179 views
3 citations

Case Report

Published on 21 Nov 2023

Case Report: Genetic profiling of small intestine metastasis from poorly differentiated non-small cell lung cancer: report of 2 cases and literature review of the past 5 years

in Thoracic Oncology

Mengqin Wang
Gang Chen
Jiang Luo
Zhipeng Fan
Yuying Liu
Conghua Xie
Yan Gong

Frontiers in Oncology

doi 10.3389/fonc.2023.1265749

1,784 views
3 citations

Navigation group

Articles

Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment

Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients

Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer

TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism

AI/ML advances in non-small cell lung cancer biomarker discovery

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

High-grade fetal adenocarcinoma of the lung misdiagnosed as male breast carcinoma: a case report and literature review

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada

Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review

Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study

PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma

Influence of treatment-related lymphopenia on the efficacy of immune checkpoint inhibitors in lung cancer: a meta-analysis

Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report

Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report

Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer

Case Report: Genetic profiling of small intestine metastasis from poorly differentiated non-small cell lung cancer: report of 2 cases and literature review of the past 5 years